Webinars

The Evolving Multiple Sclerosis Treatment Landscape

Speakers: Dr. Daniel Kantor (Neurologique) and Dr. Samuel Hunter (Advanced Neurosciences Institute)

Accountable Care Organizations: The Good, The Bad, The Unknown

Speakers: Mark Friederich (D2 Pharma Consulting) and Thomas Gustafson (Arnold & Arnold)

Improve Your CRO and Service Sales to Pharma Companies

Speaker: Dan Chupka and Kris Sarajian, BioPharm Insight

How Patient Pool Data Improves Study Feasibility and Investigator Selection - November 2012

Speaker: Bonnie A. Brescia (BBK Worldwide founding principal)

Pain Treatments and Drugs in Development - September 2012

Speaker: Dr. Edgar Ross (Pain Management Center at Brigham and Women's Hospital)

Lipid Management Drugs in Development - May 2012

Speakers: Dr. Harold Bays (Louisville Metabolic and Atherosclerosis Research Center) and Dr. Kevin Maki (Biofortis Clinical Research)

Investing in Healthcare and Life Sciences 2012 - March 2012

Speaker: Les Funtleyder (Miller Tabak + Co.)

Biogenerics: FDA Regulations and Drug Pipelines - December 2011

Speakers: Dr. Gillian Woollett (Avalere Health) and Dr. Robert Bakin (T&B Law Advisors)

The Obesity Drug Development Landscape - October 2011

Speakers: Dr. Frank Greenway (Pennington Biomedical) and Nicholas Finer (Univ. Cambridge)